series-a
Stage
1
Investors
About
Inoviv provides pre-validated, fully calibrated custom multiplexed LC-MS biomarker panels for an array of diseases, accelerating drug development and reducing risk with rapid, robust biomarker analysis.
Explore Inoviv's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.